| Item Type | Name |
|
Concept
|
Neoplasm Proteins
|
|
Academic Article
|
Mouse homologue of a novel human oncofetal antigen, glypican-3, evokes T-cell-mediated tumor rejection without autoimmune reactions in mice.
|
|
Academic Article
|
Predicting response to docetaxel neoadjuvant chemotherapy for advanced breast cancers through genome-wide gene expression profiling.
|
|
Academic Article
|
Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers.
|
|
Academic Article
|
Single nucleotide polymorphism in ABCG2 is associated with irinotecan-induced severe myelosuppression.
|
|
Academic Article
|
Enhanced RASGEF1A expression is involved in the growth and migration of intrahepatic cholangiocarcinoma.
|
|
Academic Article
|
Genome-wide association meta-analysis identifies new endometriosis risk loci.
|
|
Academic Article
|
A genome-wide association study identifies two susceptibility loci for duodenal ulcer in the Japanese population.
|
|
Academic Article
|
Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4.
|
|
Academic Article
|
A comprehensive peptidome profiling technology for the identification of early detection biomarkers for lung adenocarcinoma.
|
|
Academic Article
|
Impact of PSCA variation on gastric ulcer susceptibility.
|
|
Academic Article
|
Involvement of G-patch domain containing 2 overexpression in breast carcinogenesis.
|
|
Academic Article
|
Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer.
|
|
Academic Article
|
Isolation and characterization of a novel human gene, VANGL1, as a therapeutic target for hepatocellular carcinoma.
|
|
Academic Article
|
Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis.
|
|
Academic Article
|
The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer.
|
|
Academic Article
|
Identification of a novel human gene, ZFP91, involved in acute myelogenous leukemia.
|
|
Academic Article
|
Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for renal cell carcinoma and potential target for molecular therapy.
|
|
Academic Article
|
Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1.
|
|
Academic Article
|
Identification of an HLA-A2-restricted epitope peptide derived from hypoxia-inducible protein 2 (HIG2).
|
|
Academic Article
|
Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma.
|
|
Academic Article
|
A gene encoding a family with sequence similarity 84, member A (FAM84A) enhanced migration of human colon cancer cells.
|
|
Academic Article
|
Identification of PDZK4, a novel human gene with PDZ domains, that is upregulated in synovial sarcomas.
|
|
Academic Article
|
Isolation of LEM domain-containing 1, a novel testis-specific gene expressed in colorectal cancers.
|
|
Academic Article
|
Expression profile analysis of colon cancer cells in response to sulindac or aspirin.
|
|
Academic Article
|
Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas.
|
|
Academic Article
|
Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy.
|
|
Academic Article
|
Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor.
|
|
Academic Article
|
Effective induction of cytotoxic T cells recognizing an epitope peptide derived from hypoxia-inducible protein 2 (HIG2) in patients with metastatic renal cell carcinoma.
|
|
Academic Article
|
Multiple therapeutic peptide vaccines for patients with advanced gastric cancer.
|
|
Academic Article
|
Immunotherapy with cancer peptides in combination with intravesical bacillus Calmette-Guerin for patients with non-muscle invasive bladder cancer.
|